WallStreetZenWallStreetZen

NASDAQ: MLAB
Mesa Laboratories Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MLAB

Based on 1 analyst offering 12 month price targets for Mesa Laboratories Inc

Min Forecast
$100.00+2.99%
Avg Forecast
$100.00+2.99%
Max Forecast
$100.00+2.99%

Should I buy or sell MLAB stock?

Based on 1 analyst offering ratings for Mesa Laboratories Inc.

Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 100%
Although MLAB's forecast from analysts indicates a "Strong Sell", our proven Zen Rating quant model rates MLAB as a "Buy". Stocks with a Zen Rating of Buy have had an average return of +19.88% per year. Learn More

Be the first to know when Wall Street analysts revise their MLAB stock forecasts and price targets.

MLAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-30

1 of 1

Forecast return on equity

Is MLAB forecast to generate an efficient return?

Company
29.76%
Industry
17.47%
Market
56.76%
MLAB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MLAB forecast to generate an efficient return on assets?

Company
10.98%
Industry
10.42%
MLAB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MLAB earnings per share forecast

What is MLAB's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$8.72

MLAB revenue forecast

What is MLAB's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$255.3M+5.94%
MLAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MLAB revenue growth forecast

How is MLAB forecast to perform vs Scientific & Technical Instruments companies and vs the US market?

Company
5.94%
Industry
2.47%
Market
55.62%
MLAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MLAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MLAB vs Scientific & Technical Instrument Stocks

TickerPricePrice TargetUp/downsideConsensus
MLAB$97.10$100.00+2.99%Strong Sell
BKSY$10.89$20.00+83.65%Strong Buy
VPG$25.85N/AN/A
MVIS$1.08$2.25+108.33%Strong Buy
FARO$42.49$38.00-10.57%Hold
View Top Scientific & Technical Instrument Stocks

Mesa Laboratories Stock Forecast FAQ

Is Mesa Laboratories Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MLAB) stock is to Strong Sell MLAB stock.

Out of 1 analyst, 0 (0%) are recommending MLAB as a Strong Buy, 0 (0%) are recommending MLAB as a Buy, 0 (0%) are recommending MLAB as a Hold, 0 (0%) are recommending MLAB as a Sell, and 1 (100%) are recommending MLAB as a Strong Sell.

If you're new to stock investing, here's how to buy Mesa Laboratories stock.

What is MLAB's earnings growth forecast for 2026-2026?

(NASDAQ: MLAB) Mesa Laboratories's forecast annual earnings growth rate of N/A is not forecast to beat the US Scientific & Technical Instruments industry's average forecast earnings growth rate of 25.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Mesa Laboratories's earnings in 2025 is -$1,974,000.

In 2026, MLAB is forecast to generate $47,571,411 in earnings, with the lowest earnings forecast at $47,571,411 and the highest earnings forecast at $47,571,411.

What is MLAB's revenue growth forecast for 2026-2026?

(NASDAQ: MLAB) Mesa Laboratories's forecast annual revenue growth rate of 5.94% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 2.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.

Mesa Laboratories's revenue in 2025 is $240,978,000.

In 2026, MLAB is forecast to generate $1,392,773,066 in revenue, with the lowest revenue forecast at $1,392,773,066 and the highest revenue forecast at $1,392,773,066.

What is MLAB's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: MLAB) forecast ROA is 10.98%, which is higher than the forecast US Scientific & Technical Instruments industry average of 10.42%.

What is MLAB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MLAB price target, the average MLAB price target is $100.00, with the highest MLAB stock price forecast at $100.00 and the lowest MLAB stock price forecast at $100.00.

The Wall Street analyst predicted that Mesa Laboratories's share price could reach $100.00 by May 30, 2026. The average Mesa Laboratories stock price prediction forecasts a potential upside of 2.99% from the current MLAB share price of $97.10.

What is MLAB's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: MLAB) Mesa Laboratories's current Earnings Per Share (EPS) is -$0.36. In 2026, MLAB's EPS is forecast to hit $8.72 (min: $8.72, max: $8.72).

What is MLAB's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: MLAB) forecast ROE is 29.76%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.